4,4′-(Hexafluoroisopropylidene)diphthalic anhydride Cas:1107-00-2

We are 4,4′-(Hexafluoroisopropylidene)diphthalic anhydride CAS:1107-00-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


4,4'-(Hexafluoroisopropylidene)diphthalic anhydride

Synonyms:
6f-dianhydride
5,5'-(Perfluoropropane-2,2-diyl)bis(isobenzofuran-1,3-dione)
5-[2-(1,3-dioxo-2-benzofuran-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-benzofuran-1,3-dione
6-FDA
1,3-Isobenzofurandione, 5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-
6FDA
 
Molecular Formula: C19H6F6O6
Molecular weight:444.23800
 
Appearance and properties: white powder
Density: 1.697 g/cm3
Boiling point: 494.5ºC at 760 mmHg
Melting point: 244-247 °C(lit.)
Flash point: 243.7ºC

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
 



Market News: Both were randomised, double-blinded, placebo-controlled trials in patients with moderate to severe autoantibody-positive SLE who were receiving standard therapy. N-(2-cyanoethyl)-4-(7-oxo-1,3,4,6,7,12b-hexahydroindolo[2,3-a]quinolizin-12(2H)-yl)butanamide manufacturer.The pivotal TULIP (Treatment of Uncontrolled Lupus via the Interferon Pathway) phase III programme includes two trials, TULIP-1 and TULIP-2, that evaluated the efficacy and safety of anifrolumab versus placebo. ethyl 2,3,3,3-tetrafluoro-2-(1,1,2,3,3,3-hexafluoro-2-(1,1,2,3,3,3-hexafluoro-2-(perfluoropropoxy)propoxy)propoxy)propanoate supplier According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. 1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinolin-1-ylamine producer

Related Products
Product Name
Ethyl 8-bromooctanoate View Details
4-(4-hydroxyphenyl)cyclohexanone Cas:105640-07-1 View Details
1-(1-(3-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-Methylpiperazine Cas:761440-65-7 View Details
2-Bromo-6-methoxynaphthalene Cas:5111-65-9 manufacturer Rhodium(III) phosphate Cas:67859-71-6 manufacturer JDTic.2HCl Cas:785835-79-2 manufacturer Climbazole Cas:38083-17-9 manufacturer 2-Chloro-4-nitrophenol manufacturer